Three Rivers Pharmaceuticals is a generic drug company located in Cranberry Township, Pennsylvania. The company was formed in April 2000 with the mission of developing, manufacturing, and distributing high quality, low cost, generic prescription drugs.
Alarmed at the high costs for treatment of the hepatitis C virus (HCV), and the economic barriers to treatment being created, Three Rivers’ pharmacist-owners began researching various options to lower the cost of HCV therapy through generic drug development.After years of research and development, Three Rivers Pharmaceuticals filed an Abbreviated New Drug Application (ANDA) with the Food and Drug Administration (FDA) for Ribavirin 200 mg capsules in 2001. Three Rivers anticipates market launch in 2003.Three Rivers Pharmaceuticals will concentrate its resources on developing generic drugs for infectious diseases that have a significant national and worldwide impact. The company is dedicated to providing public education and disease state management programs.